Literature DB >> 23865862

Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.

Yang Liu1, Xiang-Yang Li, La-Gen Wan, Wei-Yan Jiang, Fang-Qu Li, Jing-Hong Yang.   

Abstract

The aim of this study was to investigate, for the first time, the combinations of carbapenem resistance mechanisms in clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing Pseudomonas aeruginosa in a Chinese hospital. Pulsed-field gel electrophoresis revealed the presence of eight clonal types among the 15 ESBL producers. Multilocus sequence typing of two isolates harboured blaIMP-1 identified the clonal strain as ST325. All these genes were found either alone or simultaneously in the strains in the following five different arrangements:<blaOXA-10>; <blaOXA-10, blaIMP-1>; <blaPER-1, blaOXA-10>; <blaPER-1, blaPSE-1>; <blaOXA-10, blaTEM-1>. Regarding mutation-driven resistance, all, but four of the isolates had a relevant decrease of oprD expression. In addition, 73.3% of the isolates overexpressed mexB, 40% mexD, and 33.3% mexY. A specific combination of overexpressed mexB or mexY and alteration in loop L710 of OprD were significantly associated with meropenem resistance. In conclusion, combination of several mutation-driven mechanisms leading to OprD inactivation and overexpression of efflux systems was the main carbapenem resistance mechanism among the ESBL-producing P. aeruginosa isolates, but acquisition of a transferable resistance determinant such as metallo-β-lactamase could be problematic in clinical settings in China.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23865862     DOI: 10.1089/mdr.2013.0010

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  2 in total

1.  In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa.

Authors:  Katherine Young; Ronald E Painter; Susan L Raghoobar; Nichelle N Hairston; Fred Racine; Douglas Wisniewski; Carl J Balibar; Artjohn Villafania; Rumin Zhang; Daniel F Sahm; Timothy Blizzard; Nicholas Murgolo; Milton L Hammond; Mary R Motyl
Journal:  BMC Microbiol       Date:  2019-07-04       Impact factor: 3.605

2.  Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.

Authors:  Camila Rizek; Liang Fu; Leticia Cavalcanti Dos Santos; Gleice Leite; Jessica Ramos; Flavia Rossi; Thais Guimaraes; Anna S Levin; Silvia Figueiredo Costa
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-09-02       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.